CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Sector valuations Charles River Laboratories International, Inc.

Stocks

CRL

US1598641074

Biotechnology & Medical Research

Market Closed - NYSE 01:30:02 03/09/2026 am IST			5-day change	1st Jan Change
291.76 ^USD	+3.34%		-1.98%	+46.26%

21/08	Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing	MT
20/08	Charles River, Medigen Partner on Multivalent Enterovirus Vaccine	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	Price to Book (Y)	PEG (Y)	EV / Sales (Y)	EV / EBITDA (Y)	EV / EBIT (Y)	Dividend Yield (Y)	Capi.($)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	75.53x	4.48x	-0.33x	3.99x	15.46x	18.99x	-.--%	1.35TCr
LONZA GROUP AG	33.93x	4.52x	1.3x	6.05x	18x	25.33x	0.95%	4.97TCr
REVOLUTION MEDICINES, INC.	-21.45x	22.19x	-0.33x	254.03x	-23.17x	-21.72x	-.--%	4.5TCr
IQVIA HOLDINGS INC.	33.27x	6.08x	-34.76x	3.24x	13.96x	21.1x	-.--%	4.25TCr
BEONE MEDICINES AG	46.98x	7.95x	0.23x	5.43x	29.72x	34.33x	-.--%	4.08TCr
CELLTRION, INC.	28.55x	2.32x	0.59x	8.63x	21.82x	25.89x	0.4%	3.29TCr
MEDPACE HOLDINGS, INC.	33.17x	23.79x	2.2x	5.43x	24.66x	25.8x	-.--%	1.63TCr
EUROFINS SCIENTIFIC SE	23.86x	2.67x	0.69x	2.08x	9x	13.93x	1.13%	1.44TCr
ICON PUBLIC LIMITED COMPANY	27.4x	1.3x	0.27x	1.82x	11.15x	12.7x	-.--%	1.25TCr
TEMPUS AI, INC.	-44.13x	22.84x	-648.2x	7.37x	180.21x	-2400x	-.--%	1.12TCr
BIO-TECHNE CORPORATION	52.24x	4.56x	2.73x	8.67x	24.61x	29.35x	0.44%	1.13TCr
PHARMARON BEIJING CO., LTD.	39.26x	4.51x	2.53x	4.6x	19.94x	31.34x	0.57%	1.06TCr
ABIVAX	-27.76x	8.17x	1.04x	108.22x	-30.81x	-53.61x	-.--%	1.07TCr
APOGEE THERAPEUTICS, INC.	-28.97x	9.3x	-2.76x	-	-25.59x	-25.65x	-.--%	1.02TCr
IONIS PHARMACEUTICALS, INC.	-16.45x	693.22x	-0.31x	10.78x	-17.28x	-16.68x	-.--%	995.11Cr
KYMERA THERAPEUTICS, INC.	-31.02x	8.94x	-7.77x	80.98x	-20.58x	-20.09x	-.--%	989.91Cr
PRAXIS PRECISION MEDICINES, INC.	-25.44x	8.79x	-8.33x	10627.11x	-20.99x	-20.67x	-.--%	986.8Cr
PROTAGONIST THERAPEUTICS, INC.	31.5x	-	-0.1x	16.49x	30.09x	29.4x	-.--%	947.91Cr
QIAGEN N.V.	22.52x	2.39x	-32.11x	4.46x	11.9x	15.17x	0.6%	897.31Cr
Average	13.31x	46.56x	-38.07x	619.97x	14.32x	-119.74x	0.22%	1.95TCr
Weighted average by Cap.	18.76x	27.80x	-24.47x	333.52x	13.49x	-61.72x	0.25%